The efficacy of the bevacizumab in combination with irinotecan(CPT-11) against lung metastasis following removal of orthotopically transplanted human colon cancer in rat

被引：0
|
作者：
Mizobe, Tomoaki [1 ]
Ogata, Yutaka [1 ]
Akagi, Yoshito [1 ]
Shirouzu, Kazuo [1 ]
机构：
[1] Kurume Univ Med, Kurume, Fukuoka, Japan
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
951
引用
收藏
页数：2
相关论文
共 31 条
  • [1] Efficacy of the MMP inhibitor MMI270 against lung metastasis following removal of orthotopically transplanted human colon cancer in rat
    Ogata, Y
    Matono, K
    Nakajima, M
    Sasatomi, T
    Mizobe, T
    Nagase, H
    Shirouzu, K
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (01) : 215 - 221
  • [2] A combination phase I study of amrubicin and irinotecan (CPT-11) in patients with lung cancer.
    Kurata, T
    Kaneda, H
    Tamura, K
    Satoh, T
    Nogami, T
    Uejima, H
    Nakagawa, K
    Fukuoka, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 703S - 703S
  • [3] Interferon potentiates antiproliferative activity of CPT-11 against human colon cancer xenografts
    Ohwada, S
    Kobayashi, I
    Maemura, M
    Satoh, Y
    Ogawa, T
    Iino, Y
    Morishita, Y
    CANCER LETTERS, 1996, 110 (1-2) : 149 - 154
  • [4] Irinotecan (CPT-11) in combination with weekly administration of cisplatin (CDDP) for non-small-cell lung cancer
    Kobayashi, K
    Shinbara, A
    Kamimura, M
    Takeda, Y
    Kudo, K
    Kabe, J
    Hibino, S
    Hino, M
    Shibuya, M
    Kudoh, S
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 42 (01) : 53 - 58
  • [5] Irinotecan (CPT-11) in combination with weekly administration of cisplatin (CDDP) for non-small-cell lung cancer
    Kunihiko Kobayashi
    Ayako Shinbara
    Mitsuhiro Kamimura
    Yuichiro Takeda
    Koichiro Kudo
    Junzaburo Kabe
    Suguru Hibino
    Mitsunori Hino
    Masahiko Shibuya
    Shouji Kudoh
    Cancer Chemotherapy and Pharmacology, 1998, 42 : 53 - 58
  • [6] ENHANCED ANTITUMOR EFFICACY OF A COMBINATION OF CPT-11, A NEW DERIVATIVE OF CAMPTOTHECIN, AND CISPLATIN AGAINST HUMAN LUNG-TUMOR XENOGRAFTS
    KUDOH, S
    TAKADA, M
    MASUDA, N
    NAKAGAWA, K
    ITOH, K
    KUSUNOKI, Y
    NEGORO, S
    MATSUI, K
    TAKIFUJI, N
    MORINO, H
    FUKUOKA, M
    JAPANESE JOURNAL OF CANCER RESEARCH, 1993, 84 (02): : 203 - 207
  • [7] Molecular mechanisms on sequence dependent antitumor efficacy of CPT-11 and 5-fluorouracil combination therapy against colon cancer cells
    Ogata, Yutaka
    Torigoe, Shoujiro
    Matono, Keiko
    Ishibashi, Nobuya
    Shirouzu, Kazuo
    CANCER RESEARCH, 2006, 66 (08)
  • [8] In vitro sensitivity of human endometrial cancer cell lines to paclitaxel or irinotecan (CPT-11) in combination with other aniticancer drugs
    Hiramatsu, HP
    Kikuchi, Y
    Seto, H
    Nagata, I
    ANTI-CANCER DRUGS, 2000, 11 (07) : 573 - 578
  • [9] Phase I study of irinotecan (CPT-11) and cisplatin (CDDP) combination in metastatic non-small cell lung cancer (NSCLC)
    Kakolyris, S
    Kouroussis, C
    Souglakos, J
    Androulakis, N
    Mavroudis, D
    Kalbakis, K
    Kotsakis, A
    Sara, E
    Agelaki, S
    Samonis, G
    Georgoulias, V
    ANNALS OF ONCOLOGY, 1998, 9 : 96 - 96
  • [10] A novel irinotecan derivative ZBH-1207 with different anti-tumor mechanism from CPT-11 against colon cancer cells
    Zhao, Dawei
    Wu, Di
    Zhang, Gengyue
    Li, Yongqi
    Shi, Weiguo
    Zhong, Bohua
    Yu, Hong
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (09) : 8359 - 8368
1234